Clinical Trials in Tennessee

Showing 9721-9740 of 20,239 trials

Short-term Clinical Deterioration After Acute Pulmonary Embolism

NCT03915925

This is a prospective, observational, multicenter cohort study to compare right ventricular dysfunction dependent and independent prognostic models for short-term serous adverse events in patients who are diagnosed with pulmonary embolism in the emergency department. Clinical endpoints are assessed at days 1-5. A thirty-day follow-up phone call is conducted to obtain further clinical endpoints and a quality of life assessment.

Pulmonary Embolism

Wake Forest University Health Sciences935 participantsStarted Sep 2018

San Diego, California, United States • Newark, Delaware, United States • Orlando, Florida, United States +3 more locations

COMPLETEDPhase 129 miles

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

NCT02923466

This is a three-part open label phase 1 study designed to determine the safety profile, MTD, PK and tumor and biomarker response after IT or IV administration of a single dose of VSV-IFNβ-NIS, or combined IT followed by IV VSV-IFNβ-NIS, with or without IV avelumab every two weeks, in patients with refractory advanced/metastatic solid tumors.

Malignant Solid Tumour

Vyriad, Inc.76 participantsStarted Apr 2017

Miami, Florida, United States • Minneapolis, Minnesota, United States • Columbus, Ohio, United States +3 more locations

Short-term Clinical Deterioration After Acute Pulmonary Embolism

Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors

Find Trials by Condition in Tennessee

The Impact of Non-Routine Events on Neonatal Safety

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Convalescent Plasma to Stem Coronavirus (CSSC-001)

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Decision Aid for Renal Therapy

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium

A Study of RG-012 in Subjects With Alport Syndrome

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.